AMG-579
CAS No. 1227067-61-9
AMG-579( AMG 579 | AMG579 )
Catalog No. M10873 CAS No. 1227067-61-9
AMG-579 is a potent, selective, CNS penetrant, orally bioavailable PDE10A inhibitor with IC50 of 0.1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 71 | In Stock |
|
| 2MG | 37 | In Stock |
|
| 5MG | 64 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAMG-579
-
NoteResearch use only, not for human use.
-
Brief DescriptionAMG-579 is a potent, selective, CNS penetrant, orally bioavailable PDE10A inhibitor with IC50 of 0.1 nM.
-
DescriptionAMG-579 is a potent, selective, CNS penetrant, orally bioavailable PDE10A inhibitor with IC50 of 0.1 nM; displays high selectivity with IC50 > 30 uM against all other PDE isoforms; demonstrates excellent target occupancy efficacy in PCP-LMA behavioral model.Schizophrenia Phase 1 Clinical.
-
In Vitro——
-
In VivoAMG 579 shows statistically significant reduction of PCP induced behavior in rats over the 2 h period. Minimum effective doses for efficacy in PCP-LMA model is determined to be 0.3 mg/kg for AMG 579. In dog, 5 exhibits superior oral bioavailability of 72%.
-
SynonymsAMG 579 | AMG579
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research AreaNeurological Disease
-
IndicationSchizophrenia
Chemical Information
-
CAS Number1227067-61-9
-
Formula Weight441.491
-
Molecular FormulaC25H23N5O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 41.67 mg/mL (94.39 mM)
-
SMILESO=C(C1=CC=C(OC2=NC=CN=C2C3CCN(C(C)=O)CC3)C=C1)C4=NC5=CC=CC=C5N4
-
Chemical Name1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hu E, et al. J Med Chem. 2014 Aug 14;57(15):6632-41.
molnova catalog
related products
-
Mirodenafil
Mirodenafil is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil (50 or 100 mg), obviously improved erectile function and was well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities.
-
Vardenafil hydrochlo...
Vardenafil hydrochloride is a New Phosphodiesterase Type 5(PDE5) Inhibitor in the Treatment of Erectile Dysfunction in Men With Diabetes.
-
SEP-0372814
SEP-0372814 is a potent inhibitor of PDE10.
Cart
sales@molnova.com